– ‘Our work is a new field of experimental therapies, such as combating the later development of liver metastasis by specific immunosuppressive cells in the liver in patients with early cancer can have great benefits, open,’said George Miller, a scientist involved in the work of the Departments of surgery and Cell Biology at New York University School of Medicine.. Mice,apeutic Target To Cancer metastasis by NYU researchers discovered stoppingresearchers discovered a very important a very important clue in answering one of the most perplexing questions about cancer: why is it spreading the liver more than any other organ? Was published in a new research report published in the April 2010 issue of the Journal of Leukocyte Biology, researchers from New York University describe experimental results suggesting that the immune system may be the reason.
The results suggest that the fight against immunosuppressive cells in the liver may be at an early stage after the development of cancer to prevent the spread of cancer to this vital organ. ‘This study might one of them”represent moments in science where one idea or experiment opens up entirely new ways of approaching and understanding a problem, ‘a-ha said Luis Montaner, Editor-in-Chief of the Journal of Leukocyte Biology. ‘The doctors have recognized that the spread of cancer to the liver too frequently occur by chance. Now we know that the immune system probably plays a role in facilitating this process. The next step is of course more more , so we can prevent it from happening.. Miller and colleagues reached this conclusion after experiments in mice. In the experiments, the mice, researchers, a problem spontaneously develops pancreatic cancer because of a mutation in the progenitor cells of the pancreas, as well as mice with advanced colon cancer to the abdomen to the abdomen. Continue reading “Our work is a new field of experimental therapies.”